The document summarizes a report on multiple sclerosis from Aarkstore Enterprise. The report provides an overview of MS, including global incidence and prevalence data. It details current treatment options for MS like beta-interferons, Copaxone, Novantrone and Tysabri. The report also includes information on treatment costs, market size, and trends. It is intended to provide a concise understanding of MS, its treatment, and the associated market.

1. ResearchAarkstoreEnterprise Disease and Therapy Review: Multiple
Sclerosis
http://www.aarkstore.com/publishers/pubreports.asp?
PubId=38&pagenum=1
http://www.aarkstore.com/search/viewresults.asp?
search=Disease&PubId=&pagenum=1
http://www.aarkstore.com/search/viewresults.asp?
search=Therapy%20&PubId=&pagenum=1
http://www.aarkstore.com/search/viewresults.asp?
search=Review&PubId=&pagenum=1
The Multiple Sclerosis Disease and Therapy Review provides and overview of the
disease and its types, global patterns and incidence and prevalence numbers for major
countries worldwide. Information on treatment is provided, as well as treatment and
dosing costs of MS drugs. General information on the MS market, as well as sales of
leading drugs and therapies are provided. Disease and Therapy Reviews were developed
to provide a basic understanding of the key facts about a disease and market in a quick,
easy-to-read format. These reports are prepared by the senior market research team of
Timely Data Resources. Each Disease and Therapy Review provides a concise analysis
of the most important information about a particular disease, its treatment, and the market
opportunities. Reports begin with an overview of the condition, and also contain tables
that summarize the available worldwide incidence and prevalence data for the condition,
a review of current diagnosis strategies and treatment options, general information about
the market size, and information about important market trends. The data contained in
these reports comes from key industry secondary data sources, such as the Timely Data
Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis
and Treatment. This information is supplemented by reviews of analyst reports, company
reports, and medical websites. Sources and references are provided.

2. Table of Contents :
I. OVERVIEW
II. INCIDENCE AND PREVALENCE
- Incidence Table: (US, UK, Spain, Worldwide)
- Prevalence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China,
India, Worldwide)
III. TREATMENT
- Beta-Interferon Products
- Copaxone
- Novantrone
- Tysabri
- Steroid Treatment
IV. DOSING
V. TREATMENT COSTS
VI. MARKET SIZE
VII. COMMENTS

3. VIII. REFERENCES/RESOURCES
For more information please visit link:
http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Multiple-Sclerosis-12804.html
Neel
Aarkstore Enterprise
Phone:08149852585
Email:enquiry@aarkstore.com
URL:www.aarkstore.com
http://www.facebook.com/aarkstoreenterprise
Disease and Therapy Review: ESRD
Disease and Therapy Review: Alzheimer Disease
Disease and Therapy Review: Migraine
Disease and Therapy Review: Stroke
Disease and Therapy Review: Rheumatoid Arthritis
Disease and Therapy Review: Obesity
Disease and Therapy Review:Major Depressive Disorder
Disease and Therapy Review: HIV/AIDS
Disease and Therapy Review: Epilepsy
Disease and Therapy Review: Parkinson's Disease
Disease and Therapy Review: Heart Failure
Disease and Therapy Review: Hepatitis C
Disease and Therapy Review: Bipolar Disorder
Disease and Therapy Review: Breast Cancer
Asthma – Executive Market Summary 2011
Bladder Cancer – Executive Market Summary 2011
Colorectal Cancer – Executive Market Summary 2011

4. Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011
Onychomycosis – Executive Market Summary 2011
Ulcerative Colitis – Executive Market Summary 2011
Impetigo – Executive Market Summary 2011